• 제목/요약/키워드: Antigen excess

검색결과 5건 처리시간 0.019초

Hitachi 7600 p-모듈을 이용한 유리형경쇄 정량검사의 항원과잉역 반응 (Antigen Excess in Free Light Chain Assay U sing the Hitachi 7600 P-module Automatic Chemistry Analyzer)

  • 차경호;김승희;송창은;심양보;채효진
    • 대한임상검사과학회지
    • /
    • 제41권4호
    • /
    • pp.173-179
    • /
    • 2009
  • The analysis of serum free light chains (sFLCs) can improve the diagnosis and monitoring of multiple myeloma and other plasma cell dyscrasias. As with other immunoassays, sFLCstests are subject to potential antigen excess and heterophilic antibody interference. We describe 9 cases of sFLCs antigen excess in patients with multiple myeloma using the FreeliteTM Human Kappa and Lambda Free Kits (The Binding Site ltd., Birmingham, UK) and the Hitachi7600 P module turbidimetric system. A total of 1,247 consecutive samples from 250 patients with multiple myeloma were assayed for sFLCs from April to September, 2009. The samples were assayed using an initial dilution of 1 :5and subsequent dilutions of 1 :50 and 1: 100. The same samples were analyzed for the presence of monoclonal gammopathies using serum protein electrophoresis (SPE) and immunofixation electrophoresis (IFE). There were 9 samples (0.72%) of antigen excess with 3 cases of kappa (0.24%) and 6 cases of lambda (0.48%). These cases represents an example of antigen excess or "hook effect" using the serum free light chain assays and mandates high level of attention to falsely low sFLC levels due to antigen excess, especially when it is disaccordant to other assay results or clinical manifestations.

  • PDF

Alternative Immunossays

  • Barnard, G.J.R.;Kim, J.B.;Collins, W.P.
    • 한국가축번식학회지
    • /
    • 제9권2호
    • /
    • pp.133-139
    • /
    • 1985
  • An immunoassay may be defined as an analytical procedure involving the competitive reaction between a limiting concentration of specific antibody and two populations of antigen, one of which is labelled or immobillized. The advent of immunoassay has revolutionised our knowledge of reproductive physiology and the practice of veterinary and clinical medicine. Radioimmunoassay (RIA) was the first of these methods to be developed, which meausred the analyte with good sensitivity, accuracy and precision (1,2). The essential components of RIA are:-(i) a limited concentration of antibodies, (ii) a reference preparation, and (iii) an antigen labelled with a radioisotope (usually tritium or iodine-125). Most procedures invelove isolating the antibody-bound fraction and measuring the amount of labelled antigen. Good facilities are available for scintilltion counting, data reduction nd statistical analysis. RIA is undergoing refinement through:-(i) the introduction of new techniques to separate the antibody-bound and free fractions which minimize the misclassification of labelled antigen into these compartments, and the amount of non-specfic binding. (3), (ii) the development of non-extration for the measurement of haptens (4), (iii) the determination of a, pp.rent free (i.e. non-protein bound) analytes (5), and (iv) the use of monoclonal antibodies(6). In 1968, Miles and Hales introduced in important new type of immunoassay which they termed immunora-diometric assay (IRMA) based on t도 use of isotopically labelled specific antibodies(7) in a move from limited to excess reagent systems. The concept of two-site IRMAs (with a capture antibody on a solid-phase, and a second labelled antibody to a different antigenic determinant of the analyte) has enabled the development of more sensitive and less-time consuming methods for the measurement of protein hormones ovar wide concentration of analyte (8). The increasing use of isotopic methos for diverse a, pp.ications has exposed several problems. For example, the radioactive half-life and radiolysis of the labelled reagent limits assay sensitivity and imposes a time limit on the usefulness of a kit. In addition, the potential health hazards associated with the use and disposal of radioactive cmpounds and the solvents and photofluors necessary for liquid scientillation counting are incompatable with the development of extra-laboratory tests. To date, the most practical alternative labels to radioisotopes, for the measurement of analytes in a concentration > 1 ng/ml, are erythrocytes, polystyrene particiles, gold sols, dyes and enzymes or cofactors with a visual or colorimetric end-point(9). Increased sensitivity to<1 pg/ml may be obtained with fluorescent and chemiluminescent labels, or enzymes with a fluorometric, chemiluminometric or bioluminometric end-point. The sensitivity of any immunoassay or immunometric assay depends on the affinity of the antibody-antigen reaction, the specific activity of the label, the precision with which the reagents are manipulated and the nonspecific background signal (10). The sensitivity of a limited reagent system for the measurement of haptens or proteins is mainly dependent upon the affinity of the antibodies and the smalleest amount of reagent that may be manipulated. Consequently, it is difficult in practice to improve on the sensitivity obtained with iodine-125 as the label. Conversely, with excess reagent systems for the measurement of proteins it is theoretically possible to increase assay sensitivity at least 1000 fold with alternative luminescent labels. To date, a 10-fold improvement has been achieved, and attempts are being made to reduce the influence of other variables on the specific signal from the immunoreaction.

  • PDF

Peroxidase-antiperoxidase(PAP) 복합체법을 이용한 돼지콜레라의 면역조직화학적 진단 (Immunohistochemical diagnosis of hog cholera with peroxidase-antiperoxidase(PAP) complex method)

  • 문운경;조희택;김순복
    • 대한수의학회지
    • /
    • 제30권2호
    • /
    • pp.215-221
    • /
    • 1990
  • The present study was intended to use the peroxidase-antiperoxidase method for the identification of hog cholera virus(HCV) in the lymphatic organs of HCV-infected pigs. Sections were incubated with primary antibody (rabbit anti-HCV polyclonal or mouse anti-HCV monoclonal), followed by incubation with linkserum (goat anti-rabbit IgG) in excess and rabbit or mouse PAP complex. The viral antigen was localized mainly in the cytoplasms of lymphoid cells and macrophages. Positive reaction cells were frequently detected in the marginal areas of the germinal centers of the spleens, and also found in the tensils and lymph nodes. The method approved to be highly specific for the identification of the virus and allowed a precise localization of the viral antigen in infected cells.

  • PDF

식약공용한약재의 아플라톡신 오염실태 조사 (A Survey of Aflatoxin Contamination in Medicinal Herbs for Food and Medicine)

  • 조성애;이성득;김동규;이현경;정선옥;김경식;유인실;정권
    • 생약학회지
    • /
    • 제45권2호
    • /
    • pp.154-160
    • /
    • 2014
  • The aim of this study was to determine the incidence and contamination levels of aflatoxin in Medicinal Herbs for Food and Medicine at Yakyeang market in seoul. 191 Samples 11 items medicinal herbs for food and medicine were evaluated for the aflatoxin contamination. in result 41 samples 10 items (21.5%) were detected in the alfatoxin, a high incidence of aflatoxins items are cassiae semen (50.0%), testudinis plastrum (43.8%) and Batryticatus Bombyx (40.0%), Polygalae Radix (31.2%), Zizyphi Semen (23.5%), Dolichoris Semen, Myristicae Semen (20.0%), Nelumbinis Semen (15.8%), Glycyrrhizae Radix et Rhizoma (7.4%), Hoveniae Semen Cum Fructus (4.3%). AFB1 were detected 27 cases (14.1%), AFB2, AFG1 and AFG2 were detected 18cases (9.4%), 16cases (8.4%) and 5cases (2.6%). The excess cancer risk estimated using the cancer potency of aflatoxin B1 (7(mg/kg/day)-1 for HBsAg-and 230(mg/kg/day)-1 HBsAg+) was N.D ~ $3.79{\times}10^{-6}$ for hepatits B surface antigen negative (HBsAg-) and N.D ~ $9.68{\times}10^{-5}$ hepatits B surface antigen positive (HBsAg+) respectively.

한약재 중 아플라톡신 분석에 관한 연구 (A study on Aflatoxins Analysis in The Herb Medicines)

  • 이성득;김연선;김남훈;정희정;정삼주;김화순;김경식;한기영
    • 한국식품위생안전성학회지
    • /
    • 제26권4호
    • /
    • pp.424-434
    • /
    • 2011
  • 서울시내에서 2010년 중 유통된 한약규격품 19종 (360건)을 구입하여 면역친화성칼럼과 유도화장치가 부착된 액체크로마토그래프를 이용하여 아플라톡신의 함량을 분석 하였다. 그 결과 전체 시료 360건 중 아플라톡선 B1은 168건 (46.4%), 아플라톡신 B2는 92건 (25.4%), 아플라톡신 G1은 137건 (37.8%) 그리고 아플라톡신 G2는 88건 (24.3%) 검출되었고, 검출량은 아플라톡신 B1 $1.4{\pm}1.8\;{\mu}g/kg$, 아플라톡신 B2는 $0.4{\pm}1.1\;{\mu}g/kg$, 아플라톡신 G1은 $1.1{\pm}5.0\;{\mu}g/kg$ 그리고 아플라톡신 G2는 $0.9{\pm}3.4\;{\mu}g/kg$이었으며, 백자인과 빈랑자를 제외한 모든 시료에서 아플라톡선 B1 허용 기준 ($10\;{\mu}g/kg$ 이하)에 적합하였다. 위해성 평가 결과 전체 시료의 초과발암위해도는 B형 간염 비보균자의 경우는 $1.30{\times}10^{-5}{\sim}1.22{\times}10^{-7}$이었고, B형 간염보균자의 경우는 $3.31{\times}10^{-4}{\sim}3.12{\times}10^{-6}$의 범위이었다. 본 연구의 대부분 시료에서 아플라톡신의 오염량은 적은 것으로 평가되었으나, 다른 종류의 곰팡이독소와 다른 경로에 의한 아플라톡신의 섭취를 감안하여, 향후 아플라톡신을 비롯한 포괄적인 곰팡이독소에 관한 연구가 진행되어야 될 것으로 생각된다.